Processa pharmaceuticals to host conference call to discuss third quarter 2022 results and provide drug development update on november 8, 2022 at 4:30 p.m. est

Hanover, md, nov. 02, 2022 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have an unmet medical need condition announces today it will host a conference call and live webcast on november 8, 2022, at 4:30 p.m. est to discuss its third quarter 2022 results and provide an update on its clinical pipeline.
PCSA Ratings Summary
PCSA Quant Ranking